|
Diabetes Mellitus
|
0.070 |
Biomarker
|
group |
BEFREE |
RFX6 heterozygotes have reduced penetrance of diabetes compared to common HNF1A and HNF4A-MODY mutations (27, 70 and 55% at 25 years of age, respectively).
|
29026101 |
2017 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous protein-truncating RFX6 variant in a family with childhood-onset, pregnancy-associated and adult-onset diabetes.
|
31001871 |
2019 |
|
Diarrhea
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Further study of patients with RFX6 mutations should clarify its role in pancreatic, intestinal and enteroendocrine cellular development and explain features such as the diarrhea exhibited in our case.
|
23914949 |
2014 |
|
Diarrhea
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Duodenal atresia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Ectopic gastric tissue
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In the embryonic intestine, the constitutive lack of Rfx6 leads to gastric heterotopia, suggesting a role in the maintenance of intestinal identity.
|
31668390 |
2019 |
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Gallbladder absent
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Gallbladder, Agenesis Of
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Hyperbilirubinemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Hyperglycemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Intestinal Atresia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotype of neonatal diabetes with intestinal atresia and biliary agenesis clearly pointed to RFX6 as the causative gene; indeed, whole exome sequencing revealed a novel homozygous RFX6 mutation c.779A>C; p.Lys260Thr (K260T).
|
23914949 |
2014 |
|
Jejunal Atresia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Recently, bi-allelic mutations in the transcription factor RFX6 were described as the cause of a rare condition characterized by neonatal diabetes with pancreatic and biliary hypoplasia and duodenal/jejunal atresia.
|
23914949 |
2014 |
|
Jejunal Atresia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
|
Malabsorption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Malabsorption Syndrome
|
0.110 |
Biomarker
|
group |
BEFREE |
Finally, we identified transcriptional changes uncovering adaptive responses to the prolonged lack of enteroendocrine hormones and leading to malabsorption and lower food efficiency ratio in Rfx6-deficient mouse intestine.
|
31668390 |
2019 |
|
Malabsorption Syndrome
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
|
Malabsorption, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Malignant neoplasm of prostate
|
0.460 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.
|
20676098 |
2010 |
|
Malignant neoplasm of prostate
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
|
26537068 |
2016 |
|
Malignant neoplasm of prostate
|
0.460 |
Biomarker
|
disease |
BEFREE |
HOXB13, RFX6 and prostate cancer risk.
|
24473320 |
2014 |
|
Malignant neoplasm of prostate
|
0.460 |
Biomarker
|
disease |
CTD_human |
Together, our results suggest that rs339331 affects prostate cancer risk by altering RFX6 expression through a functional interaction with the prostate cancer susceptibility gene HOXB13.
|
24390282 |
2014 |
|
Malignant neoplasm of prostate
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
In addition, we report here five new loci for prostate cancer susceptibility, at 5p15 (lambda-corrected probability P(GC) = 3.9 x 10(-18)), GPRC6A/RFX6 (P(GC) = 1.6 x 10(-12)), 13q22 (P(GC) = 2.8 x 10(-9)), C2orf43 (P(GC) = 7.5 x 10(-8)) and FOXP4 (P(GC) = 7.6 x 10(-8)).
|
20676098 |
2010 |
|
Malignant neoplasm of prostate
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Case-control analysis of allelic frequency of PCa associated with PCa showed that one of the 6 candidate risk loci, rs339331 in the RFX6 gene, was associated with reduced risk of prostate cancer (odds ratio (OR) = 0.73, 95% confidence interval (CI) =0.57-0.94, P = 0.013) in northern Chinese men.
|
23803082 |
2013 |
|
Malignant neoplasm of prostate
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60×10(-5)), rs12653946 (P = 1.33×10(-6)), rs1983891 (FOXP4, P = 6.22×10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42×10(-5)) with prostate cancer.
|
22662242 |
2012 |